Steven Cohen Sutro Biopharma, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 4,447,634 shares of STRO stock, worth $20 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,447,634
Previous 4,447,634
-0.0%
Holding current value
$20 Million
Previous $13 Million
-0.0%
% of portfolio
0.04%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding STRO
# of Institutions
124Shares Held
63MCall Options Held
200Put Options Held
27.6K-
Suvretta Capital Management, LLC New York, NY7.71MShares$34.7 Million0.94% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$31.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.36MShares$19.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$16 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA3.04MShares$13.7 Million1.43% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $235M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...